Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2023-05-31

Clinical Trial Update: Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ox bile-conjugated bile acids sodium in adults with type 2 diabetes mellitus and obesity; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ox bile-conjugated bile acids sodium (unknown)

Snippet

Sponsor: Mayo Clinic | Conditions: Type 2 Diabetes Mellitus, Obese | Phase 2 | Status: COMPLETED | Results posted: 2023-05-31